Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
ceritinib
×
Clear all
Filters
2
NCT02186821
2021-04-08
SIGNATURE
Novartis
Phase 2
Terminated
47 enrolled
13 charts